Wednesday, October 27, 2010

Ramadine




Ramadine may be available in the countries listed below.


Ingredient matches for Ramadine



Ranitidine

Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Ramadine in the following countries:


  • Philippines

International Drug Name Search

Friday, October 22, 2010

Oxalip




Oxalip may be available in the countries listed below.


Ingredient matches for Oxalip



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxalip in the following countries:


  • Taiwan

International Drug Name Search

Wednesday, October 20, 2010

Cefixima Labesfal




Cefixima Labesfal may be available in the countries listed below.


Ingredient matches for Cefixima Labesfal



Cefixime

Cefixime is reported as an ingredient of Cefixima Labesfal in the following countries:


  • Portugal

International Drug Name Search

Tuesday, October 19, 2010

Pelanin




Pelanin may be available in the countries listed below.


Ingredient matches for Pelanin



Estradiol

Estradiol 17ß-valerate (a derivative of Estradiol) is reported as an ingredient of Pelanin in the following countries:


  • Japan

International Drug Name Search

Monday, October 18, 2010

Indapamid Stada




Indapamid Stada may be available in the countries listed below.


Ingredient matches for Indapamid Stada



Indapamide

Indapamide is reported as an ingredient of Indapamid Stada in the following countries:


  • Austria

  • Germany

  • Slovakia

International Drug Name Search

Friday, October 15, 2010

Efézial




Efézial may be available in the countries listed below.


Ingredient matches for Efézial



Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Efézial in the following countries:


  • France

Gestodene

Gestodene is reported as an ingredient of Efézial in the following countries:


  • France

International Drug Name Search

Tuesday, October 12, 2010

Domperidon McNeil




Domperidon McNeil may be available in the countries listed below.


Ingredient matches for Domperidon McNeil



Domperidone

Domperidone maleate (a derivative of Domperidone) is reported as an ingredient of Domperidon McNeil in the following countries:


  • Netherlands

International Drug Name Search

Citrazine




Citrazine may be available in the countries listed below.


Ingredient matches for Citrazine



Piperazine

Piperazine citrate (a derivative of Piperazine) is reported as an ingredient of Citrazine in the following countries:


  • Ethiopia

International Drug Name Search

Monday, October 11, 2010

Diphenhydramine Elixir


Pronunciation: DYE-fen-HYE-dra-meen
Generic Name: Diphenhydramine
Brand Name: Examples include Benadryl Allergy and Dytuss


Diphenhydramine Elixir is used for:

Preventing or treating symptoms of hay fever and other upper respiratory allergies or the common cold, such as runny nose, sneezing, itching of the nose and throat, and itchy, watery eyes, and relieving cough. It may also be used for other conditions as determined by your doctor.


Diphenhydramine Elixir is an antihistamine and anticholinergic. It works by blocking the action of histamine, reducing the symptoms of an allergic reaction. It also works in the brain to cause sedation.


Do NOT use Diphenhydramine Elixir if:


  • you are allergic to any ingredient in Diphenhydramine Elixir or other similar medicines

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Diphenhydramine Elixir:


Some medical conditions may interact with Diphenhydramine Elixir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a fast, slow, or irregular heartbeat

  • if you have a history of asthma; chronic obstructive pulmonary disease (COPD); chronic bronchitis; lung problems (eg, emphysema); shortness of breath; sleep apnea; heart blood vessel problems; stroke; seizures; a blockage of your stomach, intestine, or bladder; difficulty urinating; diabetes; ulcers; an enlarged prostate or other prostate problems; glaucoma; heart problems; high blood pressure; the blood disease porphyria; phenylketonuria; or an overactive thyroid

Some MEDICINES MAY INTERACT with Diphenhydramine Elixir. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Sodium oxybate (GHB) because an increase in sleep duration and a decrease in the ability to breathe are likely to occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Diphenhydramine Elixir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Diphenhydramine Elixir:


Use Diphenhydramine Elixir as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Diphenhydramine Elixir by mouth with or without food.

  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.

  • Use Diphenhydramine Elixir exactly as directed on the package, unless instructed differently by your doctor. If you are taking Diphenhydramine Elixir without a prescription, follow any warnings and precautions on the label.

  • If you miss a dose of Diphenhydramine Elixir and you are taking it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Diphenhydramine Elixir.



Important safety information:


  • Diphenhydramine Elixir may cause drowsiness or dizziness. These effects may be worse if you take it with alcohol or certain medicines. Use Diphenhydramine Elixir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Diphenhydramine Elixir; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Diphenhydramine Elixir may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Do not become overheated in hot weather or while you are being active; heatstroke may occur.

  • Diphenhydramine Elixir may interfere with skin allergy tests. If you are scheduled for a skin test, talk to your doctor. You may need to stop taking Diphenhydramine Elixir for a few days before the tests.

  • Some of these products contain phenylalanine. If you must have a diet that is low in phenylalanine, ask your pharmacist if it is in your product.

  • Diphenhydramine Elixir may cause you to become sunburned more easily. Avoid the sun, sunlamps, or tanning booths until you know how you react to Diphenhydramine Elixir. Use a sunscreen or wear protective clothing if you must be outside for more than a short time.

  • Diphenhydramine Elixir has diphenhydramine in it. Before you start any new medicine, check the label to see if it has diphenhydramine in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • If your symptoms persist for more than 1 week or if you develop a fever, contact your health care provider.

  • Do not use Diphenhydramine Elixir for a cough with a lot of mucus. Do not use it for a long-term cough (eg, caused by asthma, emphysema, smoking). However, you may use it for these conditions if your doctor tells you to.

  • Use Diphenhydramine Elixir with caution in the ELDERLY; they may be more sensitive to its effects, especially dizziness, sedation, and lightheadedness upon standing.

  • Different brands of Diphenhydramine Elixir may have different dosing instructions for CHILDREN. Follow the dosing instructions on the package labeling. If your doctor has given you instructions, follow those. If you are unsure of the dose to give a child, check with your doctor or pharmacist.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Diphenhydramine Elixir while you are pregnant. Diphenhydramine Elixir is found in breast milk. If you are or will be breast-feeding while you use Diphenhydramine Elixir, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Diphenhydramine Elixir:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Dizziness; drowsiness; dry mouth, throat, and nose; excitability; thickening of mucus in nose or throat.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); convulsions; fast heartbeat or pounding in the chest; decreased alertness; hallucinations; tremor; wheezing.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.



If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include coma; excitement; hallucinations; loss of consciousness; muscle twitching; seizures; tremor; weakness.


Proper storage of Diphenhydramine Elixir:

Store Diphenhydramine Elixir at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Diphenhydramine Elixir out of the reach of children and away from pets.


General information:


  • If you have any questions about Diphenhydramine Elixir, please talk with your doctor, pharmacist, or other health care provider.

  • Diphenhydramine Elixir is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Diphenhydramine Elixir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Diphenhydramine resources


  • Diphenhydramine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Diphenhydramine Drug Interactions
  • Diphenhydramine Support Group
  • 58 Reviews for Diphenhydramine - Add your own review/rating


Compare Diphenhydramine with other medications


  • Allergic Reactions
  • Cold Symptoms
  • Cough
  • Extrapyramidal Reaction
  • Hay Fever
  • Insomnia
  • Motion Sickness
  • Nausea/Vomiting
  • Pruritus
  • Urticaria

Thursday, October 7, 2010

Beclone




Beclone may be available in the countries listed below.


Ingredient matches for Beclone



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Beclone in the following countries:


  • France

International Drug Name Search

Saturday, October 2, 2010

Natroba


Natroba is a brand name of spinosad topical, approved by the FDA in the following formulation(s):


NATROBA (spinosad - suspension; topical)



  • Manufacturer: PARAPRO PHARMS

    Approval date: January 18, 2011

    Strength(s): 0.9% [RLD]

Has a generic version of Natroba been approved?


No. There is currently no therapeutically equivalent version of Natroba available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Natroba. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Insecticide and miticide A83543 compounds and their method of production by fermentation
    Patent 5,496,931
    Issued: March 5, 1996
    Inventor(s): Boeck; LaVerne D. & Chio; Hang & Eaton; Tom E. & Godfrey, Jr.; Otis W. & Michel; Karl H. & Nakatsukasa; Walter M. & Yao; Raymond C.
    Assignee(s): DowElanco
    Fermentation product A83543, comprising major components A83543A and A83543D and minor components A83543B, A83543C, A83543E, A983543F, A83543G, A83543H and A83543J, is produced by a newly described species, Saccharopolyspora spinosa. The A83543 components and their acid-addition salts (A83543 compounds) are useful as insecticides, particularly against Lepidoptera and Diptera species. Insecticidal, miticidal or ecto-parasiticidal combinations, compositions and methods are provided.
    Patent expiration dates:

    • March 5, 2013
      ✓ 
      Patent use: TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER
      ✓ 
      Drug substance




  • Formulations for controlling human lice
    Patent 6,063,771
    Issued: May 16, 2000
    Inventor(s): Snyder; Daniel Earl
    Assignee(s): Eli Lilly and Company
    Safer pediculicidal formulations comprising a spinosyn, or a physiologically acceptable derivative or salt thereof, and a physiologically acceptable carrier, and methods of controlling lice infestations in a human with these formulations are provided.
    Patent expiration dates:

    • June 22, 2019
      ✓ 
      Patent use: TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER
      ✓ 
      Drug product




  • Formulations for controlling human lice
    Patent 6,342,482
    Issued: January 29, 2002
    Inventor(s): Daniel Earl; Snyder
    Assignee(s): Eli Lilly and Company
    Safer pediculicidal formulations comprising a spinosyn, or a physiologically acceptable derivative or salt thereof, and a physiologically acceptable carrier, and methods of controlling lice infestations in a human with these formulations are provided.
    Patent expiration dates:

    • June 22, 2019
      ✓ 
      Patent use: TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER
      ✓ 
      Drug product




  • Pediculicidal and ovacidal treatment compositions and methods for killing head lice and their eggs
    Patent 7,030,095
    Issued: April 18, 2006
    Inventor(s): Janssen; Herwig & Ho; Kie & Nystrand; Glenn & Williams; Dexter & Lamb; C. Scott
    Assignee(s): Johnson & Johnson Consumer Companies, Inc.
    The present invention relates to composition and methods for administering compositions in solutions for killing adult lice and the ova comprising water, PVM/MA Decadiene crosspolymers, propylene glycol, a mixture of cetyl and stearyl alcohols, Ceteareth-20; stearalkonium chloride; benzyl alcohol; hexylene glycol; pentylene glycol, isopropyl alcohol; a mixture of spinosyn A and spinosyn D in a weight ratio of 80:20, BHT; and sodium hydroxide.
    Patent expiration dates:

    • July 2, 2021
      ✓ 
      Patent use: TOPICAL TREATMENT OF HEAD LICE INFESTATION IN PATIENTS FOUR (4) YEARS OF AGE AND OLDER
      ✓ 
      Drug product



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • January 18, 2016 - NEW CHEMICAL ENTITY

See also...

  • Natroba Consumer Information (Drugs.com)
  • Natroba Suspension Consumer Information (Wolters Kluwer)
  • Natroba Consumer Information (Cerner Multum)
  • Natroba Advanced Consumer Information (Micromedex)
  • Spinosad Suspension Consumer Information (Wolters Kluwer)
  • Spinosad topical Consumer Information (Cerner Multum)
  • Spinosad Topical application Advanced Consumer Information (Micromedex)

Friday, October 1, 2010

Lumisteron




Lumisteron may be available in the countries listed below.


Ingredient matches for Lumisteron



Hyaluronic Acid

Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Lumisteron in the following countries:


  • Japan

International Drug Name Search